Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs
Clinical trial NCT06175637 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06175637
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-20
- Primary completion
- 2027-05-30
- Enrollment
- 409
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.